Part of the weekly research here at The Acquirer’s Multiple features some of the top picks from our Stock Screeners and some top investors who are holding these same picks in their portfolios. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and Howard Marks. The top investor data is provided from their latest 13F’s. This week we’ll take a look at:
Quest Diagnostics Inc (NYSE: DGX)
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of nearly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
A quick look at the price chart below for Quest Diagnostics shows us that the stock is up 9% in the past twelve months. We currently have the stock trading on an Acquirer’s Multiple of 8.44, which means that it remains undervalued.
Superinvestors who currently hold positions in Quest Diagnostics include:
Chris Davis – 2,778,106
Jeremy Grantham – 1,539,355
Cliff Asness – 512,701
Israel Englander – 314,137
Jim Simons – 268,700
Ray Dalio – 62,176
Rob Olstein – 62,000
Paul Tudor Jones – 53,597
Ken Griffin – 51,381
Joel Greenblatt – 26,077
Charles Brandes – 7,380
Murray Stahl – 4,812
Lee Ainslie – 2,441
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple: